|
41 |
Adaptive Choice-Based Conjoint Analysis
Enthalten in The Patient Bd. 3, 24.8.2012, Nr. 4, date:12.2010: 257-273
|
|
|
|
42 |
Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 7, date:7.2011: e1-e7
|
|
|
|
43 |
Advances in Cancer Therapeutics and Patient Access to New Drugs
Enthalten in PharmacoEconomics Bd. 29, 11.10.2012, Nr. 3, date:3.2011: 213-224
|
|
|
|
44 |
Adverse Drug Interactions
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 1, date:1.2010: 19-22
|
|
|
|
45 |
Adverse Drug Reactions of Remedies Containing Asteraceae Extracts
Enthalten in Drug safety Bd. 33, 20.11.2012, Nr. 8, date:8.2010: 705-707
|
|
|
|
46 |
Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain
Enthalten in Clinical drug investigation Bd. 32, 7.2.2013, Nr. 1, date:2.2012: 53-63
|
|
|
|
47 |
Adverse Effects of Immunosuppression in Pediatric Solid Organ Transplantation
Enthalten in Pediatric drugs Bd. 12, 22.8.2012, Nr. 1, date:2.2010: 35-49
|
|
|
|
48 |
A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 11, date:7.2012: 1543-1557
|
|
|
|
49 |
Aliskiren
Enthalten in Drugs Bd. 70, 18.9.2012, Nr. 15, date:10.2010: 2011-2049
|
|
|
|
50 |
Alogliptin
Enthalten in Drugs Bd. 70, 18.9.2012, Nr. 15, date:10.2010: 2051-2072
|
|
Administration
